Please login to the form below

Not currently logged in
Email:
Password:

Kalydeco

This page shows the latest Kalydeco news and features for those working in and with pharma, biotech and healthcare.

MPs threaten to publish Vertex’s Orkambi price if no deal struck

MPs threaten to publish Vertex’s Orkambi price if no deal struck

This “provides the potential” for Vertex to secure revenues of £1bn over the next 10 years from Orkambi, Kalydeco and newly EU-approved combination Symkevi without having to gain NICE approval.

Latest news

More from news
Approximately 6 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    Vertex has two - with Kalydeco sitting alongside Orkambi in an impressive respiratory portfolio.”.

  • Pharma deals during November 2014 Pharma deals during November 2014

    The FDA approved Vertex's cystic fibrosis drug Kalydeco in January 2012.

  • Orphan indication? No easy access Orphan indication? No easy access

    found. Governments also step in in some instances, for example in the case of Vertex Pharmaceuticals' Kalydeco (ivacaftor) for cystic fibrosis in Wales and Scotland, against HTA advice to make available ... 3. Break the rules - when you have too.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Marketing strategy in complex environments

    One example of this is in  cystic fibrosis, and the advent of disease modifying agents specific towards certain genetic mutations ( Kalydeco,   Orkambi).

  • Frontera Group

    Xarelto – Bronze HCP Digital Communications 2014 Rx Club of New York Kalydeco – Integrated Award of Excellence. ... Great People Wanted (Frontera recruitment) – Integrated Award of Excellence 2014 The Globals Kalydeco – Consumer Education

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics